IPO News | Haina Pharmaceutical Plans Hong Kong Listing, CSRC Requests Additional Details on Fund Usage

HealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical

Two Top Analysts Reveal Career Moves: Former Guosheng Securities Pharma Chief Zhang Jinyang and Former CMSC Banking Head Wang Xianshuang Join Guolian Minsheng

Guosen Securities: New U.S. Pharmaceutical Supply Chain Regulations Highlight Investment Opportunities in CXO Sector

HEALTHYWAY INC (02587) Subsidiary to Sell 51% Stake in Fujian Jianchen Pharmaceutical

New Drug Firm Xinji Pharma Files for Hong Kong IPO

Pharma Giants Ramp Up Year-End Deals: $2.5B ALS Drug Acquisition and $1.06B ADC Licensing

ABBISKO-B (02256): ABBISK Medicine's CSF-1R Inhibitor Beijiemai® Approved by China's NMPA

Qinghai Advances Standardization in Tibetan Medicine

Pharmaceutical Stocks Rebound Sharply This Morning with Asymchem and Wuxi Biologics Both Rising Over 6%

CMSC: Innovative Drug Industry Chain Remains Key Focus in Pharma Sector, Highlighting Small Nucleic Acid Technology

20 Provinces Advance Provincial-Level Medical Insurance Pooling, Accelerating Unified National Pharmaceutical Market

BIOSTAR PHARM-B (02563): First Patient Dosed in U.S. Pivotal Clinical Study of Utidelone for Breast Cancer Brain Metastasis

AH Healthcare Assets Stage Afternoon Reversal! Medical ETF Forms Bullish Engulfing Pattern at Low, Signaling Trend Shift? Heavy "Bottom-Fishing" in HK Connect Innovative Pharma, 520880 Hits Record High

First Batch of Floating-Rate Funds Show Divergence: Yinhua Growth Smart Selection A Heavily Invested in Property and Pharma, Down 3.35% YTD, Assets Shrink 56.5%

Qinghai Advances Traditional Chinese and Tibetan Medicine with Enhanced Accessibility

Fosun Pharma Acquires Green Valley Pharma: A Ray of Hope for Alzheimer's Patients?

Everbright Securities: Focus on Pharmaceutical Sector Recovery and Breakthroughs Amid Innovation Wave

Hong Kong Medical Equipment Supplier Powei Pharma (AED.US) Files for US IPO, Aims to Raise $7 Million

Hong Kong Stocks Open Lower: Hang Seng Index Down 1%, Pharmaceutical Sector Leads Declines with ASCLETIS-B (01672) Dropping Over 5%